Effects of eplerenone on cerebral aldosterone levels and brain lesions in spontaneously hypertensive rats

References

• Bollag WB. Regulation of aldosterone synthesis and secretion. Compr Physiol. 2014;4:1017–55.
   PubMed Web of Science ®Google Scholar
• Xanthakis V, Vasan RS. Aldosterone and the risk of hypertension. Curr Hypertens Rep. 2013;15:102–07. doi:10.1007/s11906-013-0330-y.
   PubMed Web of Science ®Google Scholar
• Jackson L, Eldahshan W, Fagan SC, Ergul A. Within the brain: the renin angiotensin system. Int J Mol Sci. 2018 Mar 15;19(3):E876. doi:10.3390/ijms19030876.
   PubMed Web of Science ®Google Scholar
• Huber G, Schuster F, Raasch W. Brain renin-angiotensin system in the pathophysiology of cardiovascular diseases. Pharmacol Res. 2017;125:72–90. doi:10.1016/j.phrs.2017.06.016.
   PubMed Web of Science ®Google Scholar
• Van Thiel BS, Goes Martini A, Te Riet L, Severs D, Uijl E, Garrelds IM, Leijten FP, van der Pluijm I, Essers J, Qadri F, et al. Brain renin-angiotensin system: does it exist? Hypertension. 2017;69:1136–44.
   PubMed Web of Science ®Google Scholar
• Mascolo A, Sessa M, Scavone C, De Angelis A, Vitale C, Berrino L, Rossi F, Rosano G, Capuano A. New and old roles of the peripheral and brain renin-angiotensin-aldosterone system (RAAS): focus on cardiovascular and neurological disease. Int J Cardiol. 2017;227:734–42.
   PubMed Web of Science ®Google Scholar
• Faraq E, Sessler DI, Ebrahim Z, Kurz A, Morgan J, Ahuja S, Maheshwari K, John DD. The renin angiotensin system and the brain: new developments. J Clin Neurosci. 2017;46:1–8.
   PubMed Web of Science ®Google Scholar
• Lorthois S, Lauwers F, Cassot F. Tortuosity and other vessel attributes for arterioles and venules of the human cerebral cortex. Microvasc Res. 2014;91:99–109. doi:10.1016/j.mvr.2013.11.003.
   PubMed Web of Science ®Google Scholar
• Papademetriou V. Hypertension and cognitive function. Blood pressure regulation and cognitive function: a review of the literature. Geriatrics. 2005;60:20–22, 24.
   PubMed Web of Science ®Google Scholar
• Sabbatini M, Catalani A, Consoli C, Marletta N, Tomassoni D, Avola R. The hippocampus in spontaneously hypertensive rats: an animal model of vascular dementia? Mech Ageing Dev. 2002;123:547–59. doi:10.1016/S0047-6374(01)00362-1.
   PubMed Web of Science ®Google Scholar
• Mckelvie RS, Yusuf S, Pericak D, Avezum A, Burns RJ, Probstfield J, Tsuyuki RT, White M, Rouleau J, Latini R, et al. Comparison of candesartan, enalapril and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction(RESOLVD) pilot study. Circulation. 1999;100:1056–64.
   PubMed Web of Science ®Google Scholar
• Stier CT, Chander PN, Rocha R. Aldosterone as a mediator in cardiovascular injury. Cardiol Rev. 2002;10:97–107. doi:10.1097/00045415-200203000-00008.
   PubMedGoogle Scholar
• Rudolph AE, Rocha R, McMahon EG. Aldosterone target organ protection by eplerenone. Mol Cell Endocrinol. 2004;217:229–38. doi:10.1016/j.mce.2003.10.047.
   PubMed Web of Science ®Google Scholar
• Scuteri A, Nilsson PM, Tzourio C, Redon J, Laurent S. Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications. J Hypertens. 2011;29:1469–77. doi:10.1097/HJH.0b013e328347cc17.
   PubMed Web of Science ®Google Scholar
• Maillard P, Seshadri S, Beiser A, Himali JJ, Au R, Fletcher E, Carmichael O, Wolf PA, DeCarli C. Effects of systolic blood pressure on white-matter integrity in young adults in the framingham heart study: a cross-sectional study. Lancet Neurol. 2012;11:1039–47. doi:10.1016/S1474-4422(12)70241-7.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Quevedo A, Gonzalez-Garcia S, Hernandez-Diaz Z, Fernandez Concepcion O, Quevedo Sotolongo L, Pena-Sanchez M, Marquez Rosales B, Santiesteban Freixas R, Femandez-Almirall I, Menendez-Sainz MC, et al. Serum neuron specific enolase could predict subclinical brain damage and the subsequent occurrence of brain related vascular events during follow up in essential hypertension. J Neurol Sci. 2016;363:158–63. doi:10.1016/j.jns.2016.02.052.
   PubMed Web of Science ®Google Scholar
• Rossi GP, Di BV, Ganzaroli C, Sacchetto A, Cesari M, Bertini A, Giorgi D, Scognamiglio R, Mariani M, Pessina AC. Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. Hypertension. 2002;40:23–27.
   PubMed Web of Science ®Google Scholar
• Wright JW, Harding JW. The brain renin-angiotensin system: A diversity of functions and implications for CNS diseases. Pflugers Arch. 2013;465:133–51. doi:10.1007/s00424-012-1102-2.
   PubMed Web of Science ®Google Scholar
• Chen A, Huang BS, Wang HW, Ahmad M, Leenen FHH. Konckdown of mineralocorticoid or angiotensin II type 1 receptor gene expression in the paraventricular nucleus prevents angiotensin II hypertension in rats. J Physiol. 2014;592:3523–36.
   PubMed Web of Science ®Google Scholar
• Huang BS, Chen A, Ahmad M, Wang HW, Leenen FHH. Mineralocorticoid and AT1 receptors in the paraventricular nucleus contribute to sympathetic hyperactivity and cardiac dysfunction in rats post myocardial infarct. J Physiol. 2014;592:3273–86.
   PubMed Web of Science ®Google Scholar
• Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med. 2003;115:41–46.
   PubMed Web of Science ®Google Scholar
• Bomback AS, Klemmer PJ. The incidence and implications of aldosterone breakthrough. Nat Clin Pract Nephrol. 2007;3:486–92. doi:10.1038/ncpneph0575.
   PubMedGoogle Scholar
• Schmidt BM, Schmieder RE. Aldosterone-induced cardiac damage: focus on blood pressure independent effects. Am J Hypertens. 2003;16:80–86. doi:10.1016/S0895-7061(02)03199-0.
   PubMed Web of Science ®Google Scholar
• Kosmala W, Przewlocka-Kosmala M, Szczepanik-Osadnik H, Mysiak A, O’Moore-Sullivan T, Marwick TH. A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome. JACC Cardiovasc Imaging. 2011;4:1239–49.
   PubMed Web of Science ®Google Scholar
• Pitt B, Reichek N, Willenbrock R, Zannad F, Phillips RA, Roniker B, Kleiman J, Krause S, Burns D, Williams GH. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation. 2003;108:1831–38.
   PubMed Web of Science ®Google Scholar
• Schneider A, Schwab J, Karg MV, Kalizki T, Reinold A, Bar I, Schneider MP, Schmieder RE, Schmidt BMW. Low-dose eplerenone decreases left ventricularmass in treatment-resistant hypertension. J Hypertens. 2017;35:1086–92.
   PubMed Web of Science ®Google Scholar
• Braszko JJ, Wincewicz D, Jakubow P. Candesartan prevents impairment of recall caused by repeated stress in rats. Psychopharmacology (Berl). 2013;225:421–28. doi:10.1007/s00213-012-2829-3.
   PubMed Web of Science ®Google Scholar
• Villapol S, Balarezo MG, Affram K, Saavedra JM, Symes AJ. Neurorestoration after traumatic brain injury through angiotensin II receptor blockage. Brain. 2015;138:3299–315.
   PubMed Web of Science ®Google Scholar
• Avanzini G, Depaulis A, Tassinari A, de Curtis M. Do seizures and epileptic activity worsen epilepsy and deteriorate cognitive function?. Epilepsia. 2013;54(Suppl 8):14–21. doi:10.1111/epi.12418.
   PubMed Web of Science ®Google Scholar
• Huang BS, Cheung WJ, Wang H, Tan J, White RA, Leenen FH. Activation of the brain rennin - angiotensin - aldosterone system by central sodium in Wistar rats. Am J Physiol Heart Circ Physiol. 2006;291:1109–17.
   Web of Science ®Google Scholar
• Rocha R, Stier CT. Pathophysiological effects of aldosterone in cardiovascular tissues. Trends Endocrinol Metab. 2001;12:308–14. doi:10.1016/S1043-2760(01)00432-5.
   PubMed Web of Science ®Google Scholar